Tirzepatide 20 mg is a, peptide formulation in a vial or multi-dose pen, it can be used in dealing with Type-2 Diabetes mellitus. It is a dual GIP (Glucose dependent insulinotropic polypeptide) and GLP-1 (Glucose Like Pepetide-1) receptor agonist leading to significantly improved glycemic control & weight reduction. It’s a 39-amino-acid synthetic peptide.
Key Features
| About | |
| Drug Class | Antihyperglycemic agent |
| Subclass | Dual GIP/GLP-1 receptor agonist |
| Active ingredient | Tirzepatide |
| Tirzepatide 20 mg | |
| Composition | Active ingredients
Inactive ingredients:
|
| Packaging Type | Multi-dose Prefilled pen injector |
| Pack Size | 1 Pen or vial |
| Dosage | 20 mg |
| Active ingredients | Tirzepatide |
| Manufacturer | Alluvi Healthcare |
| Shelf Life | Two years refrigerated for unopened pens. |
| Usages | Weight Management & Type 2 Diabetes |
| Country of Origin | India |
How does Tirzepatide 20 mg work?
- GIP receptor agonism: Enhances first-phase insulin secretion, improves insulin sensitivity, and may reduce food intake via central action.
- GLP-1 receptor agonism: Stimulates glucose-dependent insulin secretion, suppressed glucagon, slow gastric emptying, increases satiety.
Usage
- It is used in treating Type 2 diabetes Mellitus.
- Chronic weight management in adults.
(This is not for Type 1 diabetes, history of medullary thyroid carcinoma of MEN2, pregnancy)
Dosage
- Tirzepatide is administered once a week via subcutaneous injection with incremental dosage adjustment.
Side effects
- Nausea
- Diarrhea
- Decreased appetite
- Vomiting
- Constipation
- Dyspepsia
- Abdominal pain
- Pancreatitis
- Gallbladder disease
- Acute kidney injury from dehydration
- Severe gastroparesis
- Hypersensitivity
- Hypoglycaemia
Interactions
- Oral meds may delay gastric emptying, it may impact absorption. Take narrow therapeutic index orals 1 hr before injection.
- Insulin Sulfonylureas, it may increase the risk of hypoglycaemia.
- Oral contraceptives may reduce the effectiveness of meds due to delayed absorption. In such situation backup method for 4 weeks after starting/ increasing dose can be used.
- Warfarin, it also interacts adversely
- Alcohol consumption may increase the risk of side effects like nausea, increases pancreatitis risk.
Pharmacokinetics
- Half-life is about 5 days, supports once-weekly dosing.
- Tmax is about 8-72 hours post SubQ injection.
- Metabolism may include proteolytic cleavage to peptides/amino acids.
- Excretion via urine & feces as metabolites.
- Steady state: approx. 4 weeks.
- Bioavailability: approx. 80% SubQ.
Precautions
- Prior history of pancreatitis or severe GI disease should avoid taking such medications.
- The one with Gallbladder disease should also avoid taking such medications.
- Diabetic retinopathy, here rapid glucose lowering may get worsen.
- Renal impairment, may increase dehydration rusk with GI side effects.
- If symptoms like Suicidal behaviour & ideation can be seen then should avoid taking such medications.
- It can be refrigerated at 2-8 °C but do not freeze.
Conclusion
Tirzepatide 20 mg is a safe and effective peptide formulation in a vial or multi-dose pen, it can be used in dealing with Type-2 Diabetes mellitus. It is a dual GIP (Glucose dependent insulinotropic polypeptide) and GLP-1 (Glucose Like Pepetide-1) receptor agonist leading to significantly improved glycemic control & weight reduction. It may show some side effects like Nausea, diarrhea, decreased appetite, vomiting, constipation, dyspepsia, abdominal pain, pancreatitis and gallbladder disease this side effects may vary from individual to individual, so need to consult your healthcare provider prior using any such medications.
FAQs
- For what purpose Tirzepatide 20 mg is used?
Tirzepatide 20 mg can be used in dealing with Type 2 Diabetes Mellitus and also for weight management.
- How does Tirzepatide 20 mg may work?
Tirzepatide 20 mg may work by it may works by enhancing first-phase insulin secretion, it may improve insulin sensitivity and acts on GIP receptors in the brain to reduce food intake and increase satiety.
- What can be the possible side effects of Tirzepatide 20 mg?
The possible side effects can be Nausea, diarrhea, decreased appetite, vomiting, constipation, dyspepsia, abdominal pain, pancreatitis and gallbladder disease.
- Is Tirzepatide safe?
Yes, Tirzepatide is safe when used up-to 15 mg, but need to consult your healthcare provider prior taking any such medications or while increasing dosage.
- What is onset of action of Tirzepatide 20 mg?
It may reaches at the peak plasma concentration about 8-72 hours after subcutaneous injection.
Note: Tirzepatide is a prescription medicine and this is for educational purpose only. Please prior using any such medications consult your healthcare provider.
tyler webb –
I have been able to drastically reduce the amount of food that I eat